|
|
| Countries covered: United States In this annual report, PharmaLive editors detail information about prescription drugs in development and on the market in the United States, including new chemical entities, indications and formulations. The drugs are separated into sections by their approved or development status. Each section provides the product's commercial name or product code, chemical or substance composition, the approved or intended application, and developer with company website. |
More United States Drug Discovery Reports
Special Report: Thought-Leader Opinion on the Current and Future Landscape of the Age-Related Macular Degeneration Market by
Decision Resources
Age-related macular degeneration (AMD) is a degenerative and progressive ocular disease that diminishes central vision acuity as a result of photoreceptor degeneration in the macula. ...
Drugs in Development: From Pipeline to Market 2011 by
PharmaLive Special Reports
In this annual compilation, PharmaLive analysts detail information about prescription medicines in clinical development as well as those approved for marketing in the United States ...
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development by
GBI Research
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development Summary GBI Research has released ...
Psoriasis Market Info™ by
Drug Market Info
Psoriasis is a chronic skin disease that is the most prevalent autoimmune disease in the U.S. with as many as 7.5 million Americans affected (2.5% ...
U.S. Asthma/COPD Market by
Frost & Sullivan
This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
- Life Sciences
- Pharmaceuticals
- Pharmaceuticals
- Research & Development
- Prescription Drugs
- Drug Discovery
Drug Discovery Reports
- Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
- Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012

